Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,708.23
(
-0.26%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: DewDiligence post# 203165

Friday, 08/05/2016 9:48:40 AM

Friday, August 05, 2016 9:48:40 AM

Post# of 257268
Dew, how do you think this will impact Opdivo NSCLC combination therapies? For instance, Heat Biologics has this trial using Opdivo for NSCLC.
http://ir.heatbio.com/press-releases/detail/525/heat-biologics-presents-a-poster-on-its-hs-110nivolumab

Would HTBX now be more attractive because of it's potential to increase Opdivo response rate in NSCLC?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today